Stock 0QF MODERNA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Moderna, Inc. Berne S.E.

Equities

0QF

US60770K1079

Delayed Berne S.E.
Other stock markets
 09:30:00 15/04/2024 pm IST 		5-day change 1st Jan Change
96.41 CHF +1.01% Intraday chart for Moderna, Inc. -39.82% -47.70%
15/07 Moderna Insider Sold Shares Worth $1,756,177, According to a Recent SEC Filing MT
12/07 China approves CSPC Pharma's RSV vaccine for clinical trials RE

Evolution of the average Target Price on Moderna, Inc.

Price target over the last 5 years

History of analyst recommendation changes

68.YUryPmr_bzp72O_ndlbTR_Swl8I_JCMugspOxuFKwvE.UR2ifRqKI0wt4I7RRD-HMIbe1vV7bBRk8rw3tJgr8MJVK5x4NYYCDBmeog~efda9be791eddc75a9d57b6b1ef34515

Analyst Recommendations on Moderna, Inc.

Moderna Insider Sold Shares Worth $1,756,177, According to a Recent SEC Filing MT
Redburn Raises Moderna's Price Target to $117 From $116 MT
Argus Raises Moderna's Price Target to $150 From $115 MT
JPMorgan Raises Price Target on Moderna to $96 From $85 MT
Oppenheimer Raises Price Target on Moderna to $179 From $163 MT
Moderna Insider Sold Shares Worth $30,087,339, According to a Recent SEC Filing MT
Jefferies Adjusts Price Target on Moderna to $180 From $155, Keeps Buy Rating MT
RBC Raises Moderna's PT to $160 From $135 Amid RSV Vaccine Approval From US FDA, Keeps Outperform Rating MT
RBC Raises Price Target on Moderna to $160 From $135 Amid RSV Vaccine Approval From FDA, Keeps Outperform Rating MT
MODERNA : Oddo BHF raises its target price on the stock CF
ANALYSTS RECOMMENDATIONS : Best Buy, Dell Technologies, Moderna, AMD, National Grid... Our Logo
Moderna Insider Sold Shares Worth $2,901,585, According to a Recent SEC Filing MT
RBC Raises Moderna's Price Target to $160 From $135 MT
Moderna Insider Sold Shares Worth $1,909,863, According to a Recent SEC Filing MT
Moderna Insider Sold Shares Worth $1,912,350, According to a Recent SEC Filing MT
Arbutus Biopharma Urged to Stop Share Issuances, Explore Alternatives for Hepatitis B Program MT
ANALYST RECOMMENDATIONS : Nike, Roblox, Starbucks, Walmart, Deckers Outdoor... Our Logo
Evercore ISI Initiates Moderna With In Line Rating, $120 Price Target MT
Moderna Insider Sold Shares Worth $1,825,220, According to a Recent SEC Filing MT
Deutsche Bank Raises Moderna's Price Target to $85 From $70 MT
UBS Adjusts Moderna Price Target to $151 From $143, Maintains Buy Rating MT
Moderna Insider Sold Shares Worth $1,663,855, According to a Recent SEC Filing MT
Jefferies Adjusts Price Target on Moderna to $155 From $125 MT
Oppenheimer Adjusts Price Target on Moderna to $163 From $142 MT
Goldman Sachs Adjusts Price Target on Moderna to $204 From $206 MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
125.1 USD
Average target price
145.9 USD
Spread / Average Target
+16.59%
High Price Target
310 USD
Spread / Highest target
+147.72%
Low Price Target
62 USD
Spread / Lowest Target
-50.46%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Moderna, Inc.

Argus
JPMorgan Chase
Oppenheimer
Jefferies & Co.
RBC Capital Markets
Evercore ISI
Deutsche Bank Securities
UBS
Goldman Sachs
Leerink Partners
Morgan Stanley
Redburn
HSBC
Canaccord Genuity
RBC Luca Issi
TD Cowen
William Blair & Co.
Guggenheim
SVB Securities LLC
Cowen
Chardan Research
Piper Sandler
SVB Leerink
BofA Securities
Wolfe Research
Barclays
Chardan
J.P. Morgan Chase

Ratings for Moderna, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. MRNA Stock
  4. 0QF Stock
  5. Consensus Moderna, Inc.